{"height":"190","description":"iPS\u7d30\u80de\u304b\u3089\u8840\u5c0f\u677f\u3092\u4f5c\u308a\u3001\u96e3\u75c5\u306b\u8f38\u8840\u3059\u308b\u81e8\u5e8a\u7814\u7a76\u306e\u5b9f\u65bd\u304c\u4e86\u627f\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u4e16\u754c\u521d\u306e\u4e8b\u3067\u3001\u6765\u5e74\u521d\u3081\u306b\u3082\u5b9f\u65bd\u4e88\u5b9a\u3067\u3059\u3002Kyoto University got the health ministry go-ahead Sept. 21 to begin the world's first clinical study to infuse blood platelets made from induced pluripotent stem (iPS) cells into a patient suffering from aplastic anemia, an intractable dise\u2026","blog_url":"https://a30.hatenablog.com/","image_url":null,"width":"100%","author_name":"A30","version":"1.0","provider_name":"Hatena Blog","title":"intractable \u5fa9\u7fd2","url":"https://a30.hatenablog.com/entry/20180923/1537659021","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fa30.hatenablog.com%2Fentry%2F20180923%2F1537659021\" title=\"intractable \u5fa9\u7fd2 - \u5e38\u6642\u82f1\u5fc3\uff1a\u8a00\u8449\u306e\u68ee\u304b\u3089 1.0\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_url":"https://blog.hatena.ne.jp/A30/","type":"rich","categories":["\u82f1\u8a9e\u306e\u843d\u3061\u7a42\u62fe\u3044"],"blog_title":"\u5e38\u6642\u82f1\u5fc3\uff1a\u8a00\u8449\u306e\u68ee\u304b\u3089 1.0","published":"2018-09-23 08:30:21","provider_url":"https://hatena.blog"}